Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: Association with human papillomavirus type

Journal of the National Cancer Institute

Volumn 90, Issue 6, 1998, Pages 433-439

  Muller, Carolyn Y ^a,b   O'Boyle, John D ^a   Fong, Kwun M ^b   Wistuba, Ignacio I ^b   Biesterveld, Eric ^b   Ahmadian, Mohsen ^b   Miller, David S ^b   Gazdar, Adi F ^a   Minna, John D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0032542697     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.6.433     Document Type: Article

References (22)

1. Wistuba II, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 1997;57:3154-8.
2. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995;273:1908.
3. Chen LC, Matsumura K, Deng G, Kurisu W, Ljung BM, Lerman MI, et al. Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res 1994;54:3021-4.
4. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Muller-Brechlin R, Klein G, et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A 1988;85:1571-5.
5. Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S, Boiocchi M. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res 1993;53:5775-9.
6. Jones MH, Nakamura Y. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene 1992;7:1631-4.
7. Kohno T, Takayama H, Hamaguchi M, Takano H, Yamaguchi N, Tsuda H, et al. Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 1993;8:1825-32.
8. Karlsen F, Rabbitts PH, Sundresan V, Hagmar B. PCR-RFLP studies on chromosome 3p in formaldehyde-fixed, paraffin-embedded cervical cancer tissues. Int J Cancer 1994;58:787-92.
9. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW, et al. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 1996;5:187-95.
10. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
11. Beahrs OH, Henson DC, Hutter RVP, Myers MH, editors. Manual for staging of cancer. 3rd ed. Philadelphia: Lippincott, 1988:151-3.
12. Kingston RE. Preparation of RNA from eukaryotic and prokaryotic cells. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Current protocols in molecular biology. New York: John Wiley & Sons, 1997.
13. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, et al. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 1997;57:2256-67.
14. Sozzi G, Alder H, Tornielli S, Corletto V, Baffa R, Veronese ML, et al. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 1996;56: 2472-4.
15. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, et al. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 1996;85:17-26.
16. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci U S A 1996;93:9770-5.
17. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 1996;56:3173-9.
18. Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda D, Saboorian MH, et al. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res 1997;57:3664-8.
19. Thiagalingam S, Lisitsyn NA, Hamaguchi M, Wigler MH, Willson JD, Markowitz SD, et al. Evaluation of the FHIT gene in colorectal cancers. Cancer Res 1996;56:2936-9.
20. Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, et al. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet 1997;6:193-203.
21. Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvilli Z, Baffa R, et al. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 1997;57:504-12.
22. Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M, et al. FHIT mutations in human primary gastric cancer. Cancer Res 1997;57: 1435-7.